Montesinos Emilio
Institute of Food and Agricultural Technology-CeRTA-CIDSAV, Universitat de Girona, Av. Lluís Santaló s/n, 17071 Gerona, Spain.
Int Microbiol. 2003 Dec;6(4):245-52. doi: 10.1007/s10123-003-0144-x. Epub 2003 Sep 3.
Plant protection against pathogens, pests and weeds has been progressively reoriented from a therapeutic approach to a rational use of pesticide chemicals in which consumer health and environmental preservation prevail over any other productive or economic considerations. Microbial pesticides are being introduced in this new scenario of crop protection and currently several beneficial microorganisms are the active ingredients of a new generation of microbial pesticides or the basis for many natural products of microbial origin. The development of a microbial pesticide requires several steps addressed to its isolation in pure culture and screening by means of efficacy bioassays performed in vitro, ex vivo, in vivo, or in pilot trials under real conditions of application (field, greenhouse, post-harvest). For the commercial delivery of a microbial pesticide, the biocontrol agent must be produced at an industrial scale (fermentation), preserved for storage and formulated by means of biocompatible additives to increase survival and to improve the application and stability of the final product. Despite the relative high number of patents for biopesticides, only a few of them have materialized in a register for agricultural use. The excessive specificity in most cases and biosafety or environmental concerns in others are major limiting factors. Non-target effects may be possible in particular cases, such as displacement of beneficial microorganisms, allergenicity, toxinogencity (production of secondary metabolites toxic to plants, animals, or humans), pathogenicity (to plants or animals) by the agent itself or due to contaminants, or horizontal gene transfer of these characteristics to non-target microorganisms. However, these non-target effects should not be evaluated in an absolute manner, but relative to chemical control or the absence of any control of the target disease (for example, toxins derived from the pathogen). Consumer concerns about live microbes due to emerging food-borne diseases and bioterrorism do not help to create a socially receptive environment to microbial pesticides. The future of microbial pesticides is not only in developing new active ingredients based on microorganisms beneficial to plants, but in producing self-protected plants (so-called plant-incorporated pesticides) by transforming agronomically high-value crop plants with genes from biological control agents.
植物针对病原体、害虫和杂草的保护措施已逐渐从治疗方法转向合理使用农药化学品,其中消费者健康和环境保护优先于任何其他生产或经济考虑因素。微生物农药正被引入这种新的作物保护场景中,目前有几种有益微生物是新一代微生物农药的活性成分,或是许多微生物源天然产物的基础。开发一种微生物农药需要几个步骤,包括在纯培养物中分离并通过体外、离体、体内或在实际应用条件(田间、温室、收获后)下的中试试验进行功效生物测定来筛选。为了商业交付微生物农药,生物防治剂必须进行工业化规模生产(发酵),保存以便储存,并通过生物相容性添加剂进行配方,以提高存活率并改善最终产品的应用和稳定性。尽管生物农药的专利数量相对较多,但其中只有少数已在农业用途登记中实现。大多数情况下的过度特异性以及其他情况下的生物安全或环境问题是主要限制因素。在特定情况下可能会出现非靶标效应,例如有益微生物的替代、致敏性、毒素生成(产生对植物、动物或人类有毒的次生代谢产物)、病原体本身或由于污染物导致的致病性(对植物或动物),或这些特性向非靶标微生物的水平基因转移。然而,这些非靶标效应不应以绝对方式评估,而应相对于化学防治或对目标病害不进行任何防治的情况(例如,病原体产生的毒素)。由于新出现的食源性疾病和生物恐怖主义,消费者对活微生物的担忧不利于营造社会对微生物农药的接受环境。微生物农药的未来不仅在于开发基于对植物有益的微生物的新活性成分,还在于通过用生物防治剂的基因转化具有农业高价值的作物来培育自我保护的植物(所谓的植物内源性农药)。